Abolition of spinal motor disturbance by injections of dopamine receptor agonists, atropin and GABA into the caudate nucleus.
D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology*; D002421:Caudate Nucleus; D005260:Female; D006892:Hydroxydopamines / Q000494:pharmacology; D007267:Injections; D008297:Male; D009046:Motor Neurons / Q000187:drug effects*; D009116:Muscarine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013116:Spinal Cord / Q000166:cytology / Q000187:drug effects*; D013378:Substantia Nigra; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000494:pharmacology*
D000613:Aminobutyrates; D006892:Hydroxydopamines; D011954:Receptors, Dopamine; D005680:gamma-Aminobutyric Acid; D009538:Nicotine; D001285:Atropine; D009116:Muscarine; D012110:Reserpine